Skip to content

PMN

ProMIS Neurosciences, Inc.

NASDAQ · Healthcare · Biotechnology · CA

$14.01
+4.09%
Ask drillr

Next report

Analyst consensus

Next report date
Nov 11, 2026
EPS estimate
-$1.31
Revenue estimate

Latest reported

Last report date
Aug 13, 2026
EPS actual
-$1.28
EPS estimate
-$1.38
Revenue actual
Revenue estimate

Track record

Trailing twelve quarters

EPS beats (12Q)
6
EPS misses (12Q)
4
EPS in line (12Q)
0
Avg surprise (4Q)
-15.0%
Revenue beats (12Q)

Analyst ratings

Sell-side consensus

Consensus
Buy
Price target
$43
PT range
$18 – $100
Analysts
5
5 Buy0 Hold0 Sell
Earnings call history
Reported history
Report dateEPS estimateEPS actualSurpriseRevenue actual
Aug 13, 2026-$1.38-$1.28Beat 7.25%
May 12, 2026-$1.06-$1.26Miss -18.87%
Mar 25, 2026-$4.66-$4.11Beat 11.80%
Nov 12, 2025-$3.75-$6.00Miss -60.00%
Aug 13, 2025-$0.22-$0.29Miss -31.82%
Mar 31, 2025-$0.14-$0.02Beat 85.71%
Nov 14, 2024-$0.07-$0.14Miss -100.00%
Aug 8, 2024-$0.14-$0.13Beat 7.14%
Apr 1, 2024-$0.17-$0.09Beat 47.06%$4.7K
Nov 14, 2023-$0.33-$0.19Beat 42.42%
Aug 14, 2023-$0.27
May 15, 2023-$0.58

Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 11, 2026